Development of a novel blood-sparing agent in cardiac surgery: do we need another agent?

Anesth Analg. 2014 Jul;119(1):11-12. doi: 10.1213/ANE.0000000000000225.

Authors

David Faraoni¹, Jerrold H Levy

Affiliation

¹ From the Department of Anesthesiology, Queen Fabiola Children's University Hospital, Free University of Brussels, Brussels, Belgium; and Department of Anesthesiology and Intensive Care, Duke University School of Medicine, Durham, North Carolina.

PMID: 24945119
DOI: 10.1213/ANE.0000000000000225

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antifibrinolytic Agents / pharmacokinetics*
Cardiopulmonary Bypass*
Coronary Artery Bypass*
Female
Humans
Male
Serine Proteinase Inhibitors / pharmacokinetics*

Substances

Antifibrinolytic Agents
Serine Proteinase Inhibitors